SARS-CoV-2, Furuwenza A&B Antigen Yakasanganiswa Yekuona Kit-EU CE

COVID-19, Flu A kana Flu B vane zviratidzo zvakafanana, zvichiita kuti zviome kusiyanisa pakati pehutachiona hutatu hwehutachiona. Kuongororwa kwakasiyana kwekurapa kwakanangana kunoda kuongororwa kwakasanganiswa kuona hutachiona.

Zvinodiwa

Kunyatso siyanisa kuongororwa kwakakosha kutungamira kwakakodzera antiviral therapy.

Kunyangwe vachigovana zviratidzo zvakafanana, COVID-19, Flu A uye Flu B hutachiona hunoda kurapwa kwakasiyana.Furuwenza inogona kurapwa neuraminidase inhibitors uye yakaoma COVID-19 ine remdesivir/sotrovimab.

Positive mhedzisiro muhutachiona humwe hazvirevi kuti wakasununguka kubva kune vamwe.Co-infections inowedzera njodzi dzechirwere chakakomba, kuchipatara, kufa nekuda kwe synergistic mhedzisiro.

Kuongororwa kwakaringana kuburikidza nekuongororwa kwemultiplex kwakakosha kutungamira kwakakodzera antiviral kurapwa, kunyanya nekugona hutachiona hwehutachiona panguva yepamusoro yehutachiona hwekufema.

Our Solutions

Macro & Micro-Test'sSARS-CoV-2, Influenza A&B Antigen Yakasanganiswa Kuonekwa, inosiyanisa Flu A, Flu B neCCIDID-19 pamwe chete neanogona hutachiona hwakawanda munguva yechirwere chekufema;

Kukurumidza kuyedzwa kwezvirwere zvakawanda zvekufema, kusanganisira SARS-CoV-2, Flu A, uye Flu B nemuenzaniso mumwe;

Yakanyatsobatanidzwa test strip ine nzvimbo imwe chete yekushandisa uye imwe sampu inodiwa kusiyanisa pakati peCovid-19, Flu A neFlu B;

4 matanho chete ekukurumidza inoguma mune chete 15-20 min, zvichiita kuti kukurumidza kuita sarudzo yekiriniki.

Mhando dzakawanda dzemuenzaniso: Nasopharyngeal, Oropharyngeal kana Nasal;

Kuchengetedza Tembiricha: 4 -30°C;

Sherufu Hupenyu: 24 Mwedzi.

Mamiriro mazhinji sezvipatara, makiriniki, nzvimbo dzehutano dzenharaunda, ma pharmacy, nezvimwe.

SARS-CoV-2

Flu A

FluB

Sensitivity

94.36%

94.92%

93.79%

Zvakananga

99.81%

99.81%

100.00%

Kururama

98.31%

98.59%

98.73%


Nguva yekutumira: Jan-18-2024